PFIZER ICU QUIZ

Eraxis® (Anidulafungin) is proven efficacious for invasive candidiasis in ICU patients: (20%)

True

False

According to Eraxis® (Anidulafungin) product insert, which of the following is true regarding dosage adjustment for different patient profile? (20%)

Hepatic and renal dysfunction – no dose adjustment required

Hepatic and renal dysfunction – dose adjustment required

Hepatic dysfunction - dose adjustment required

Renal dysfunction – dose adjustment required

{"name":"PFIZER ICU QUIZ", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"Eraxis® (Anidulafungin) is proven efficacious for invasive candidiasis in ICU patients: (20%), According to Eraxis® (Anidulafungin) product insert, which of the following is true regarding dosage adjustment for different patient profile? (20%)","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}